GURUGRAM, HARYANA- May 19, 2023- DDReg is pleased to announce its participation as exhibitor at the DIA 2023 Global Annual Meeting in Boston from the 25th to 28th of June- an event that brings together Life Sciences, Healthcare, and Scientific industry leaders to discuss some of the key trends within the industry including emerging trends in regulatory affairs.
Outsourcing regulatory affairs has demonstrated the value it brings to a business in terms of saving on cost & resources, bringing greater ROI, and de-risking functions. In a tech-driven era, organizations that have leveraged smart-tech platforms into their regulatory functions are indeed ahead of their contemporaries who have yet to embrace the technology in their processes. The paradigm shift within regulatory function, from manual to technology-enabled operations, is one that is revolutionizing processes to ensure efficient and rapid market access for newer therapies and as well as affordable generics.
For about 14 years, DDReg has been supporting global organizations for their end-to-end Regulatory outsourcing requirements including CMC & regulatory strategies, due diligence, new product authorizations, gap analysis & remediation, API/DMF, and post-lifecycle management.
Keeping in line with the rapidly evolving technological era, DDReg has been able to develop in-house technologies that combine its subject-matter expertise, operational excellence, and smart-tech platform to curate a web-based proprietary tool. Named as VITALIC®, the SmarTech platform accelerates the regulatory review processes, efficiently accesses market specific regulatory intel, automates labelling changes, and tracks global regulatory submissions with the click of a button. VITALIC®, the Regulatory Submission Management and Compliance tool, is a one-stop solution for regulatory, project management, document management, artwork management, regulatory intelligence, registration, tracking, and monitoring requirements that help pharmaceutical organizations stay ahead of the changing regulatory environment for rapid product market access.
The Business Development team at DDReg will be present at the DIA Global Annual Meeting in Boston to discuss avenues in which DDReg can provide technology-enabled regulatory solutions to pharmaceutical organizations for efficient submissions to deliver them rapid market access. Schedule a meeting with the team at booth # 387 here: Meet DDReg at DIA Global in Boston Email the team at [email protected]
DDReg is a globally renowned Regulatory and Pharmacovigilance service provider that was founded in 2009. It is headquartered in Gurugram, Haryana- also known as the Millenium City of India- with operating offices in the cities of Mumbai and Hyderabad, and a virtual office in Wilmington, Delaware.
DDReg has worked alongside over 120 regulatory agencies and submitted over 1700 filings in regulated and emerging markets. These include USA, EU, UK, GCC, MENA, LatAM, APAC, and CIS. Its niche product area of expertise includes generics, biologics, biosimilars, consumer products, and medical devices. In addition to Regulatory Affairs, DDReg has provided its customers with comprehensive support for Pharmacovigilance- including ICSR Processing & Submission, local QPPV/LSR, Literature Monitoring, Signal Management- Medico-Regulatory & Safety Writing, Strategic and Regulatory Intelligence Advisory Services, Publishing, Labeling, Artwork Management, IPR, Audits, Clinical & Regulatory Reports, Certification Services for Regulatory Submissions, and more.
The Business Development team shall be exhibiting at the DIA Global Annual Meeting in Boston from 25th to 28th of June.